Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 1446194 BALA CYNWYD, PA

Position in XFOR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,536,196
+$3,447,656 QoQ
Shares Held
856,222
+3768.2% QoQ
Ownership
0.908%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Derivatives in XFOR

reported options exposure · as of Dec 31, 2025
CallValue
$511,600
CallShares
127,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,162,367,415 across 355 Biotechnology names. XFOR ranks #70 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XFOR

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,536,196 856,222
2025-12-31 $88,540 22,135
2025-12-31 $511,600 127,900
2025-09-30 $437,418 127,900
2025-06-30 $243,010 127,900
2025-06-30 $66,159 34,821